Senior insider sale
GENERAL COUNSEL & CORP SEC at STOKE THERAPEUTICS, INC. — senior position signals high conviction
$107.9K
3.49K shares
What this filing means
ALLAN JONATHAN plans to sell 3.49K shares of STOKE THERAPEUTICS, INC. valued at approximately $107.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/2/2026ACC: 0001950047-26-010004
Officer· GENERAL COUNSEL & CORP SEC
Since Feb 2026
3.49K
Shares to sell
$107.9K
Approx. market value
627.00
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
9/30/2026
627.00Total acquired627.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/30/2026 | Restricted Stock Units N/A | 627.00 | — |
| Total | 627.00 | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.86K
Market value
$91.6K
8/18/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
627.00
Market value
$16.3K
10/2/2026
Total
Units
3.49K
Value
$107.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/18/2026 | 2.86K | $91.6K | — | Completed |
| Planned — Approximate Date | ||||
10/2/2026 | 627.00 | $16.3K | NASDAQ | Planned |
| Total | 3.49K | $107.9K | ||